Skip to main content
Top
Published in: International Journal of Clinical Pharmacy 1/2014

01-02-2014 | Short Research Report

Non-adherence to antibiotic therapy in patients visiting community pharmacies

Authors: Milene Fernandes, Andreia Leite, Maria Basto, Miguel Araújo Nobre, Nuno Vieira, Rui Fernandes, Paulo Nogueira, Paulo Jorge

Published in: International Journal of Clinical Pharmacy | Issue 1/2014

Login to get access

Abstract

Background Patient non-adherence to antibiotic therapy may lead to therapeutic failure, re-infection, and bacterial resistance. Assessing the factors associated with this problem is important for promoting rational use of antibiotics. Objective This study aimed to measure prevalence and reasons for non-adherence to antibiotic treatment and to identify associated factors. Method Patients were recruited for the study in community pharmacies in Lisbon, Portugal, from February to April, 2009. Data from prescriptions for oral antibiotics were collected for adult subjects. Adherence to treatment was assessed with a modified Portuguese version of the Morisky scale. Factors associated with non-adherence were identified through bivariate analysis and logistic regression models. Results A total of 243 patients were included in the study. They had a mean age 46.5 ± 16.6 years and 74.5 % of the sample was female. The prevalence of non-adherence was 57.7 % and was related to delays and failures in taking the prescribed medicine. Increasing age (OR 0.97), difficulty in buying the antibiotic (OR 2.34), duration of treatment (OR 1.28), difficulty with ingestion (OR 3.08), and satisfaction with the information given by physician (OR 0.33) were identified as independent factors associated with non-adherence. Conclusion Non-adherence to antibiotics is common in the community setting. Factors related to the antibiotic, the patient, and the patient-physician relationship should be addressed to promote adherence. Pharmacists should provide information to patients about correct use of antibiotics and address barriers to adherence.
Literature
1.
go back to reference European Centre for Disease Prevention and Control. Antimicrobial resistance surveillance in Europe 2011. Annual Report of the European Antimicrobial Resistance Surveillance Network (EARS-Net). Stockholm: ECDC; 2012. ISBN 978-92-9193-398-3. European Centre for Disease Prevention and Control. Antimicrobial resistance surveillance in Europe 2011. Annual Report of the European Antimicrobial Resistance Surveillance Network (EARS-Net). Stockholm: ECDC; 2012. ISBN 978-92-9193-398-3.
2.
go back to reference Goossens H, Ferech M, Vander Stichele R, Elseviers M, ESAC Project Group. Outpatient antibiotic use in Europe and association with resistance: a cross-national database study. Lancet. 2005;365(9459):579–87.PubMed Goossens H, Ferech M, Vander Stichele R, Elseviers M, ESAC Project Group. Outpatient antibiotic use in Europe and association with resistance: a cross-national database study. Lancet. 2005;365(9459):579–87.PubMed
3.
go back to reference Kardas P. Patient compliance with antibiotic treatment for respiratory tract infections. J Antimicrob Chemother. 2002;49:897–903.PubMedCrossRef Kardas P. Patient compliance with antibiotic treatment for respiratory tract infections. J Antimicrob Chemother. 2002;49:897–903.PubMedCrossRef
4.
go back to reference Pechere JC, Hughes D, Kardas P, Cornaglia G. Non-compliance with antibiotic therapy for acute community infections: a global survey. Int J Antimicrob Agents. 2007;29:245–53.PubMedCrossRef Pechere JC, Hughes D, Kardas P, Cornaglia G. Non-compliance with antibiotic therapy for acute community infections: a global survey. Int J Antimicrob Agents. 2007;29:245–53.PubMedCrossRef
5.
6.
go back to reference Adriaenssens N, Coenen S, Versporten A, Muller A, Minalu G, Faes C, ESAC Project Group. European Surveillance of Antimicrobial Consumption (ESAC): outpatient antibiotic use in Europe (1997–2009). J Antimicrob Chemother. 2011;66(Suppl 6):vi3–12.PubMed Adriaenssens N, Coenen S, Versporten A, Muller A, Minalu G, Faes C, ESAC Project Group. European Surveillance of Antimicrobial Consumption (ESAC): outpatient antibiotic use in Europe (1997–2009). J Antimicrob Chemother. 2011;66(Suppl 6):vi3–12.PubMed
7.
go back to reference Ramalhinho I, Ribeirinho M, Vieira I, Cabrita J. Evolution of outpatient antibiotic use in Portugal mainland 2000–2009. Acta Med Port. 2012;25(1):20–8.PubMed Ramalhinho I, Ribeirinho M, Vieira I, Cabrita J. Evolution of outpatient antibiotic use in Portugal mainland 2000–2009. Acta Med Port. 2012;25(1):20–8.PubMed
8.
go back to reference Branco MJ, Nogueira PJ, Marinho Falcão JC, Melo M, Martins AP. Uses, misuses and abuses… Patient utilization of antibiotics. Lisboa: ONSA; 2000. Branco MJ, Nogueira PJ, Marinho Falcão JC, Melo M, Martins AP. Uses, misuses and abuses… Patient utilization of antibiotics. Lisboa: ONSA; 2000.
9.
go back to reference André M, Vernby A, Berg J, Lundborg CS. A survey of public knowledge and awareness related to antibiotic use and resistance in Sweden. J Antimicrob Chemother. 2010;65(6):1292–6.PubMedCrossRef André M, Vernby A, Berg J, Lundborg CS. A survey of public knowledge and awareness related to antibiotic use and resistance in Sweden. J Antimicrob Chemother. 2010;65(6):1292–6.PubMedCrossRef
10.
go back to reference WHO. Collaborating Centre for Drug Statistics Methodology. Guidelines for ATC classification and DDD assignment, 2013. Oslo, 2012. ISBN: 978-82-8082-525-4. WHO. Collaborating Centre for Drug Statistics Methodology. Guidelines for ATC classification and DDD assignment, 2013. Oslo, 2012. ISBN: 978-82-8082-525-4.
11.
go back to reference WHO. International statistical classification of diseases and related health problems. 10th revision ed, 2010. Geneva; 2010. ISBN: 978-92-4-154834-2. WHO. International statistical classification of diseases and related health problems. 10th revision ed, 2010. Geneva; 2010. ISBN: 978-92-4-154834-2.
12.
go back to reference Delgado AB, Lima ML. Contribution to the concurrent validity of a measure of adherence to treatment. Psic Saúde Doenças. 2001;2(2):81–100. Delgado AB, Lima ML. Contribution to the concurrent validity of a measure of adherence to treatment. Psic Saúde Doenças. 2001;2(2):81–100.
13.
go back to reference Morisky DE, Lawrence WG, Levine DM. Concurrent and predictive validity of a self-reported measure of medication adherence. Med Care. 1986;24:67–74.PubMedCrossRef Morisky DE, Lawrence WG, Levine DM. Concurrent and predictive validity of a self-reported measure of medication adherence. Med Care. 1986;24:67–74.PubMedCrossRef
14.
go back to reference Cals JW, Hopstaken RM, Le Doux PH, Driessen GA, Nelemans PJ, Dinant GJ. Dose timing and patient compliance with two antibiotic treatment regimens for lower respiratory tract infections in primary care. Int J Antimicrob Agents. 2008;31:531–6.PubMedCrossRef Cals JW, Hopstaken RM, Le Doux PH, Driessen GA, Nelemans PJ, Dinant GJ. Dose timing and patient compliance with two antibiotic treatment regimens for lower respiratory tract infections in primary care. Int J Antimicrob Agents. 2008;31:531–6.PubMedCrossRef
15.
go back to reference Vrijens B, Urquhart J. Patient adherence to prescribed antimicrobial drug dosing regimens. J Antimicrob Chemother. 2010;55:616–27.CrossRef Vrijens B, Urquhart J. Patient adherence to prescribed antimicrobial drug dosing regimens. J Antimicrob Chemother. 2010;55:616–27.CrossRef
17.
go back to reference Morris AB, Li J, Kroenke K, Bruner-England TE, Young JM, Murray MD. Factors associated with drug adherence and blood pressure control in patients with hypertension. Pharmacotherapy. 2006;26(4):483–92.PubMedCrossRef Morris AB, Li J, Kroenke K, Bruner-England TE, Young JM, Murray MD. Factors associated with drug adherence and blood pressure control in patients with hypertension. Pharmacotherapy. 2006;26(4):483–92.PubMedCrossRef
18.
go back to reference Rolnick SJ, Pawloski PA, Hedblom BD, Asche SE, Bruzek RJ. Patient characteristics associated with medication adherence. Clin Med Res. 2013;11(2):54–65.PubMedCentralPubMedCrossRef Rolnick SJ, Pawloski PA, Hedblom BD, Asche SE, Bruzek RJ. Patient characteristics associated with medication adherence. Clin Med Res. 2013;11(2):54–65.PubMedCentralPubMedCrossRef
19.
go back to reference Lindenmeyer A, Hearnshaw H, Vermeire E, Van Royen P, Wens J, Biot Y. Interventions to improve adherence to medication in people with type 2 diabetes mellitus: a review of the literature on the role of pharmacists. J Clin Pharm Ther. 2006;31(5):409–19.PubMedCrossRef Lindenmeyer A, Hearnshaw H, Vermeire E, Van Royen P, Wens J, Biot Y. Interventions to improve adherence to medication in people with type 2 diabetes mellitus: a review of the literature on the role of pharmacists. J Clin Pharm Ther. 2006;31(5):409–19.PubMedCrossRef
20.
go back to reference Rubio-Valera M, Serrano-Blanco A, Magdalena-Belío J, Fernández A, García-Campayo J, Pujol MM, et al. Effectiveness of pharmacist care in the improvement of adherence to antidepressants: a systematic review and meta-analysis. Ann Pharmacother. 2011;45(1):39–48.PubMedCrossRef Rubio-Valera M, Serrano-Blanco A, Magdalena-Belío J, Fernández A, García-Campayo J, Pujol MM, et al. Effectiveness of pharmacist care in the improvement of adherence to antidepressants: a systematic review and meta-analysis. Ann Pharmacother. 2011;45(1):39–48.PubMedCrossRef
Metadata
Title
Non-adherence to antibiotic therapy in patients visiting community pharmacies
Authors
Milene Fernandes
Andreia Leite
Maria Basto
Miguel Araújo Nobre
Nuno Vieira
Rui Fernandes
Paulo Nogueira
Paulo Jorge
Publication date
01-02-2014
Publisher
Springer Netherlands
Published in
International Journal of Clinical Pharmacy / Issue 1/2014
Print ISSN: 2210-7703
Electronic ISSN: 2210-7711
DOI
https://doi.org/10.1007/s11096-013-9850-4

Other articles of this Issue 1/2014

International Journal of Clinical Pharmacy 1/2014 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine